During the COVID-19 pandemic, life sciences investment surged, with biotech stock valuations and IPO funding peaking in 2021. However, investment has declined significantly, leading to tightening R&D belts and streamlined…
"Statistically based experimental designs have been available for over a century. However, many preclinical researchers are completely unaware of these methods, and the success of experiments is usually equated only…
"Statistical power analysis provides the conventional approach to assess error rates when designing a research study. However, power analysis is flawed in that a narrow emphasis on statistical significance is…
Clinical trial findings are often simplified into a binary conclusion, focusing on a P value of less than 0.05 for a treatment difference. However, a more nuanced interpretation requires examining…
Main Ideas Null hypothesis significance testing (NHST) is the prevalent statistical method in biology, but it has significant limitations. NHST fails to provide two critical aspects: 1. the magnitude of…